Remove Branding Remove Pharmacy Remove Regulation
article thumbnail

The drug industry continues to dare regulation

World of DTC Marketing

A new study estimates the causal effects of coupons for branded drugs without bioequivalent generics using variation in coupon introductions over time and comparing differential responses across enrollees in commercial and Medicare Advantage plans. ” More checks from PhRMA to politicians are coming up.

article thumbnail

Pharma brands must ‘up the ante’ in their digital presence

pharmaphorum

Each country has different regulations in regard to the online advertising of prescription drugs and over-the-counter medicines. In the UK, Google allows the promotion of online pharmacies providing they follow Google’s procedures and are registered with the relevant pharmaceutical authorities in the countries their ad campaign targets.

Branding 124
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Supply chain middlemen ‘pocket half of US branded medicine spending’

pharmaphorum

In 2020, over half of total spending on brand medicines went to the supply chain, middlemen and other stakeholders, overtaking the amount going to drug manufacturers for the first time, according to a new study. ” The post Supply chain middlemen ‘pocket half of US branded medicine spending’ appeared first on. .

Branding 111
article thumbnail

The social media problem for healthcare

World of DTC Marketing

From my estimates, most of it failed because pharma companies are afraid of misinformation concerning regulations around DTC marketing. It was reported this week by The Guardian that ads from brands like Nike, Amazon, Honda, Walgreens, eBay, and other substantial advertisers were popping up all over anti-vax sites.

Branding 224
article thumbnail

Disruption in healthcare is coming

World of DTC Marketing

The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Generic drugs versus branded is also a considerable expense. If pharmacies try to fill those generic prescriptions, the claims are rejected.

Pharmacy 227
article thumbnail

Do generics producers have what it takes to tackle complex and specialty drugs?

Pharmaceutical Technology

For example, JAK inhibitors are oral drugs that feature a certain complexity, says Jonathan Watanabe, PhD, professor of Clinical Pharmacy at the University of California, Irvine. Unlike biosimilars, it is simpler for small molecule specialty generics to establish equivalence to their branded forms, explains Vasquez.

Drugs 298
article thumbnail

Our abysmal health care system

World of DTC Marketing

87% of doctors say patients’ conditions have worsened because of red-tape regulations, and 83% worry the patients will suffer prolonged pain. Part D plans differ in premiums, deductibles, co-pays, formularies, tiers, and preferred pharmacies. No one would worry about which pharmacy is in or out of network.

Doctors 263